Publications by authors named "Giuliana Caruso"
Article Synopsis
- Psoriasis is a long-lasting inflammatory disease with no known cure, often requiring ongoing treatment, especially for moderate to severe cases.
- A study evaluated the long-term effectiveness of anti-TNFα biologic agents (infliximab, etanercept, adalimumab) in 210 psoriatic patients over a decade, finding that about one-third of them maintained good results with their treatments.
- The median survival rates for the treatments were approximately 9.5-10 years, suggesting these agents can be effective long-term, but more research is needed to identify factors affecting treatment success or failure over time.
Vaccination is the most effective method to prevent and control the SARS-CoV-2 infection and biologics are not considered a contraindication for vaccination. The burning question is that safety data are lacking since patients taking drugs affecting the immune system were excluded from clinical trials leading to vaccine approbation. Moreover, it seems that vaccination could worsen psoriasis.
View Article and Find Full Text PDF